IRM mutiparamétrique de la prostate avant biopsies : la fin des biopsies systématisées ?

Noldus, 2000, Stage migration in clinically localized prostate cancer, Eur Urol, 38, 74, 10.1159/000020255 Epstein, 1994, Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA, 271, 368, 10.1001/jama.1994.03510290050036 Stamey, 1993, Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer, Cancer, 71, 933, 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L Haas, 2007, Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence, J Natl Cancer Inst, 99, 1484, 10.1093/jnci/djm153 Mozer, 2009, Mapping of transrectal ultrasonographic prostate biopsies: quality control and learning curve assessment by image processing, J Ultrasound Med, 28, 455, 10.7863/jum.2009.28.4.455 Boccon-Gibod, 2006, Prostate saturation biopsy in the reevaluation of microfocal prostate cancer, J Urol, 176, 961, 10.1016/j.juro.2006.04.013 Lucia, 2008, Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention, Cancer Prev Res, 1, 167, 10.1158/1940-6207.CAPR-08-0078 Schröder, 2009, ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084 Villers, 2006, Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings, J Urol, 176, 2432, 10.1016/j.juro.2006.08.007 Delongchamps, 2011, Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging, BJU Int, 107, 1411, 10.1111/j.1464-410X.2010.09808.x Bittencourt, 2012, diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason grades than TRUS-guided biopsies in peripheral zone tumours, Eur Radiol, 22, 468, 10.1007/s00330-011-2269-1 Delongchamps, 2011, Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer, Prostate Cancer Prostatic Dis, 14, 232, 10.1038/pcan.2011.9 Ouzzane, 2011, Committee of Infectious Diseases of the French Association of Urology (CIAFU); Committee of Cancerology of the French Association of Urology (CCAFU). Recommendations for best practice for prostate biopsy, Prog Urol, 21, 18, 10.1016/j.purol.2010.07.001 Haute Autorité de Santé (HAS) : recommandations pour la pratique clinique. Éléments d’information des hommes envisageant la réalisation d’un dépistage individuel du cancer de la prostate. Anaes 2004. http://www.has-sante.fr/portail/upload/docs/application/pdf/information_kp_recommandations-2006.pdf. Dynamique d’évolution des taux de mortalité des principaux cancers en France. Institut National du Cancer. Novembre 2010. www.e-cancer.fr. Nam, 2010, Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy, J Urol, 183, 963, 10.1016/j.juro.2009.11.043 Turkbey, 2011, Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds, J Urol, 186, 1818, 10.1016/j.juro.2011.07.013 Park, 2011, Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy, AJR Am J Roentgenol, 197, W876, 10.2214/AJR.11.6829 Haffner, 2011, Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection, BJU Int, 108, 171, 10.1111/j.1464-410X.2011.10112.x Ahmed, 2009, Is ittime to consider a role for MRI before prostate biopsy?, Nat Rev Clin Oncol, 6, 197, 10.1038/nrclinonc.2009.18